Gene description for S100A13
Gene name S100 calcium binding protein A13
Gene symbol S100A13
Other names/aliases -
Species Homo sapiens
 Database cross references - S100A13
ExoCarta ExoCarta_6284
Entrez Gene 6284
HGNC 10490
MIM 601989
UniProt Q99584  
 S100A13 identified in exosomes derived from the following tissue/cell type
Hepatocellular carcinoma cells 26054723    
Mesenchymal stem cells Unpublished / Not applicable
Prostate cancer cells 25844599    
Prostate cancer cells 25844599    
 Gene ontology annotations for S100A13
Molecular Function
    zinc ion binding GO:0008270 IDA
    lipid binding GO:0008289 IEA
    protein binding GO:0005515 IPI
    fibroblast growth factor binding GO:0017134 IPI
    calcium ion binding GO:0005509 IDA
    protein homodimerization activity GO:0042803 IPI
    copper ion binding GO:0005507 IDA
    RAGE receptor binding GO:0050786 IPI
Biological Process
    interleukin-1 alpha secretion GO:0050703 IDA
    response to copper ion GO:0046688 IEA
    response to electrical stimulus GO:0051602 IEA
    mast cell degranulation GO:0043303 NAS
    cytokine secretion GO:0050663 IMP
    positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123 IDA
    positive regulation of cell proliferation GO:0008284 IEA
    regulation of cell shape GO:0008360 IEA
Subcellular Localization
    cytosol GO:0005829 IDA
    perinuclear region of cytoplasm GO:0048471 IDA
    extracellular exosome GO:0070062 IDA
    nucleus GO:0005634 IDA
    cytoplasm GO:0005737 IDA
    mast cell granule GO:0042629 NAS
    extracellular space GO:0005615 IDA
 Experiment description of studies that identified S100A13 in exosomes
1
Experiment ID 236
ISEV standards
EM
EV Biophysical techniques
TSG101|Alix|HSC70|GAPDH
EV Cytosolic markers
EV Membrane markers
HSP90B1
EV Negative markers
qNano
EV Particle analysis
Identified molecule mRNA
Identification method RNA Sequencing
PubMed ID 26054723    
Organism Homo sapiens
Experiment description Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs
Authors He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N
Journal name Carcinogenesis
Publication year 2015
Sample Hepatocellular carcinoma cells
Sample name MHCC97L
Isolation/purification methods Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient
Flotation density 1.13-1.19 g/mL
Molecules identified in the study Protein
RNA
Methods used in the study Western blotting
Mass spectrometry
RT-PCR
RNA Sequencing
2
Experiment ID 126
ISEV standards
EV Biophysical techniques
GAPDH
EV Cytosolic markers
EV Membrane markers
EV Negative markers
EV Particle analysis
Identified molecule protein
Identification method Mass spectrometry [LTQ-FT Ultra]
PubMed ID Unpublished / Not applicable
Organism Homo sapiens
Experiment description Mesenchymal Stem Cell Exosomes: The Future MSC-based Therapy?
Authors Ruenn Chai Lai, Ronne Wee Yeh Yeo, Soon Sim Tan, Bin Zhang, Yijun Yin, Newman Siu Kwan Sze, Andre Choo, and Sai Kiang Lim
Journal name Mesenchymal Stem Cell Therapy
Publication year 2011
Sample Mesenchymal stem cells
Sample name huES9.E1
Isolation/purification methods HPLC
Flotation density -
Molecules identified in the study Protein
Methods used in the study Western blotting
Antobody array
Mass spectrometry
3
Experiment ID 275
ISEV standards
EM
EV Biophysical techniques
TSG101|Alix|RAB5A
EV Cytosolic markers
CD9|CD82|CD63|CD81
EV Membrane markers
AIF
EV Negative markers
NTA
EV Particle analysis
Identified molecule protein
Identification method Mass spectrometry
PubMed ID 25844599    
Organism Homo sapiens
Experiment description Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
Authors Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T.
Journal name Oncotarget
Publication year 2015
Sample Prostate cancer cells
Sample name DU145 - Docetaxel sensitive
Isolation/purification methods Filtration
Ultracentrifugation
Sucrose density gradient
Flotation density 1.12-1.19 g/mL
Molecules identified in the study Protein
Methods used in the study Mass spectrometry/Flow cytometry/Western blotting
4
Experiment ID 274
ISEV standards
EM
EV Biophysical techniques
TSG101|Alix|RAB5A
EV Cytosolic markers
CD9|CD82|CD63|CD81
EV Membrane markers
AIF
EV Negative markers
NTA
EV Particle analysis
Identified molecule protein
Identification method Mass spectrometry
PubMed ID 25844599    
Organism Homo sapiens
Experiment description Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
Authors Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T.
Journal name Oncotarget
Publication year 2015
Sample Prostate cancer cells
Sample name DU145 - Docetaxel resistant
Isolation/purification methods Filtration
Ultracentrifugation
Sucrose density gradient
Flotation density 1.13-1.18 g/mL
Molecules identified in the study Protein
Methods used in the study Mass spectrometry
Flow cytometry
Western blotting
 Protein-protein interactions for S100A13
  Protein Interactor ExoCarta ID Identification method PubMed Species
1 IL1A  
Affinity Capture-MS Homo sapiens
Affinity Capture-Western Homo sapiens
2 SYT1 6857
Invivo Homo sapiens
Invitro Homo sapiens
Co-purification Homo sapiens
3 VCL 7414
Affinity Capture-MS Homo sapiens
4 PHYHIP 9796
Two-hybrid Homo sapiens
5 FGF1  
Affinity Capture-MS Homo sapiens
Invivo Homo sapiens
Invitro Homo sapiens
Co-purification Homo sapiens
View the network image/svg+xml
 Pathways in which S100A13 is involved
No pathways found





Perform bioinformatics analysis of your extracellular vesicle data set using FunRich, a open access standalone tool. NEW UPDATED VERSION OF FunRich available for download (12/09/2016) from here